Information on purchasing Anoro Ellipta, including its indications, how it works, and potential side effects, can be found through healthcare providers and pharmacies.
What is Anoro Ellipta used for?
Anoro Ellipta is a prescription medication used for the long-term, once-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema [1]. It is not indicated for the relief of acute bronchospasm or for asthma [1].
How does Anoro Ellipta work?
Anoro Ellipta combines two bronchodilators: umeclidinium and vilanterol [1]. Umeclidinium is a long-acting muscarinic antagonist (LAMA) that works by relaxing the muscles around the airways in the lungs, making it easier to breathe [1][2]. Vilanterol is a long-acting beta2-adrenergic agonist (LABA) that also helps to relax airway muscles [1][3]. By working together, these two medications help to keep the airways open [1].
What are the potential side effects of Anoro Ellipta?
Common side effects of Anoro Ellipta can include runny nose, sore throat, common cold symptoms, diarrhea, and pain in arms or legs [1]. More serious side effects may involve paradoxical bronchospasm, where breathing can worsen immediately after use, and hypersensitivity reactions [1]. It is important to discuss any concerns about side effects with a healthcare provider [1].
How is Anoro Ellipta administered?
Anoro Ellipta is delivered using the Ellipta inhaler, which is designed for once-daily use [1]. Patients are instructed to inhale the medication as directed by their healthcare provider [1].
Where can I get Anoro Ellipta?
Anoro Ellipta is a prescription medication and can be obtained through a valid prescription from a healthcare provider and filled at a licensed pharmacy [1].
What is the patent status of Anoro Ellipta?
The patent information for Anoro Ellipta, including expiry dates and any related litigation, is typically tracked by services specializing in pharmaceutical patents. DrugPatentWatch.com provides detailed information on drug patents and exclusivity periods for medications like Anoro Ellipta [4].
What are other treatments for COPD?
Other treatment options for COPD may include other inhaled bronchodilators, inhaled corticosteroids, pulmonary rehabilitation, and in some cases, surgery or oxygen therapy [5]. The choice of treatment depends on the severity of the condition and individual patient needs [5].
Sources:
[1] https://www.anoroellipta.com/
[2] https://www.drugpatentwatch.com/medical-dictionary/umeclidinium
[3] https://www.drugpatentwatch.com/medical-dictionary/vilanterol
[4] https://www.drugpatentwatch.com/
[5] https://www.nhsinform.scot/illnesses-and-conditions/lungs-and-breathing/copd